Investment to support the continued evaluation and redevelopment of KALA’s product candidates and patent portfolio, and provide working capital and funding for a potential future strategic transaction ...
Kala Bio focuses on developing therapies for rare and severe diseases of the eye using its proprietary mesenchymal stem cell secretome platform. Its lead product candidate, KPI-012, had previously ...
Gestern war ich erneut bei TARZAN in der Neuen Flora – nach meinem ersten Besuch 2013. Und obwohl ich den Animationsfilm von 1999 sehr schätze, vor allem wegen seiner starken musikalischen Identität, ...
ARLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback